Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
524.00    4.00 (0.77%)
Bid:
524.00
Ask:
528.00
Spread: 4.00 (0.763%)
Market Cap: £867.04m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Total Voting Rights

1 Aug 2025 07:00

RNS Number : 5033T
Oakley Capital Investments Limited
01 August 2025
 

1 August 2025

Oakley Capital Investments Limited

Total Voting Rights

 

In conformity with Disclosure and Transparency Rule 5.6.1, Oakley Capital Investments Limited1 (the "Company") announces the following:

As of 31 July 2025, the Company had 171,421,749 ordinary shares of £0.01 each in issue and admitted to trading on the London Stock Exchange's main market, none of which were held in treasury.

The total number of voting rights in the Company is 171,421,749. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Oakley Capital Investments Limited under the FCA's Disclosure and Transparency Rules.

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

 

Greenbrook

+44 20 7952 2000

Rob White / Michael Russell

 

Deutsche Numis (Financial Adviser & Broker)

+44 20 7260 1000

Nathan Brown / Matt Goss

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

About Oakley Capital Investments Limited ("OCI")

OCI is a closed-ended investment fund trading on the main market of the London Stock Exchange as an Official List Company. OCI aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/

The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

The Oakley Funds

Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V, Oakley Capital VI, Oakley Capital Origin and Oakley Capital Origin II are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

Important information

Oakley Capital Investments has now been admitted to the Official List of the Financial Conduct Authority. Therefore, the Company is now required to satisfy the eligibility criteria for admission to listing on the Official List is required to comply with the Financial Conduct Authority's Listing Rules, including in relation to transactions with related parties, financial reporting, contents of shareholder circulars and other continuing obligations.

This announcement may include "forward-looking statements". These forward-looking statements are statements regarding the Company's objectives, intentions, beliefs or current expectations with respect to, amongst other things, the Company's financial position, business strategy, results of operations, liquidity, prospects and growth. Forward-looking statements are subject to risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Accordingly the Company's actual future financial results, operational performance and achievements may differ materially from those expressed in, or implied by, the statements. Given these uncertainties, prospective investors are cautioned not to place any undue reliance on such forward-looking statements, which speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the Company's expectations with regard to them or any change in events, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Regulation Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRWPUPGMUPAPUG
Date   Source Headline
15th Dec 20217:00 amRNSSale of TechInsights and follow-on investment
2nd Dec 202110:30 amEQSHardman Talks | Oakley Capital Investments Webinar: Everything you wanted to know about private equity but were afraid to ask!
1st Dec 202112:45 pmEQSHardman & Co: Hardman Talks Video Event | Oakley Capital Investments Live Q&A Webinar
25th Oct 20212:30 pmEQSHardman & Co Research: Q&A on Oakley Capital Investments (OCI) | Pipeline looks strong with new deals being announced regularly
21st Sep 20212:06 pmRNSDirector Dealing
14th Sep 20217:00 amRNSOakley Capital invests in Seedtag
13th Sep 20213:41 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): 1H'21: 35% EBITDA growth drives 26% NAV return
9th Sep 20217:00 amRNSResults for the Six Months ended 30 June 2021
25th Aug 20217:00 amRNSNotice of Interim Results and Webcast Presentation
23rd Aug 20211:13 pmRNSHolding(s) in Company
13th Aug 20212:09 pmRNSHolding(s) in Company
12th Aug 202112:16 pmRNSHolding(s) in Company
2nd Aug 202112:37 pmRNSHolding(s) in Company
30th Jul 20215:57 pmRNSHolding(s) in Company
30th Jul 202111:29 amRNSHolding(s) in Company
29th Jul 20215:32 pmRNSTransaction in Own Shares
29th Jul 20217:00 amRNSShare Buy-Back Programme
28th Jul 20217:00 amRNSTrading Update for the Six Months Ended 30 June 21
27th Jul 20217:00 amRNSResult of AGM
21st Jul 202112:46 pmRNSHolding(s) in Company
1st Jul 202112:22 pmRNSChange of Administrator
29th Jun 20218:55 amRNSKepler Trust Intelligence: New Research
28th Jun 20217:00 amRNSSale of ACE Education and follow-on investment
28th Jun 20217:00 amRNSNotice of Annual General Meeting
24th Jun 20215:56 pmRNSHolding(s) in Company
24th Jun 20215:52 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSDirector Dealing
22nd Jun 20217:00 amRNSInvestment in Primavera
11th Jun 20217:30 amEQSHardman & Co Research: Hardman & Video | Q&A with Mark Thomas on Oakley Capital Investment (OCI)
7th Jun 20217:00 amRNSInvestment in Afterbuy and DreamRobot
3rd Jun 20214:50 pmRNSHolding(s) in Company
1st Jun 20217:00 amRNSInvestment in ICP Education
25th May 20211:40 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): 2021 Capital Markets day: proof of the pudding
13th May 20215:25 pmRNSHolding(s) in Company
30th Apr 20214:29 pmRNSHolding(s) in Company
30th Apr 20213:29 pmRNSHolding(s) in Company
22nd Apr 20218:42 amRNSHolding(s) in Company
21st Apr 20217:00 amRNSCapital Markets Day
16th Apr 20213:54 pmRNSHolding(s) in Company
12th Apr 20214:03 pmRNSHolding(s) in Company
30th Mar 20219:10 amEQSHardman & Co Research : Hardman Talks Video | Oakley Capital Investments
22nd Mar 20219:30 amRNSHardman & Co: Sustained and sustainable NAV growth
15th Mar 20215:35 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
9th Mar 20212:05 pmEQSHardman & Co Research : Hardman Talks | Oakley Capital Investments Management Discussion
1st Mar 20217:00 amRNSRefinancing of Career Partner Group
23rd Feb 20217:00 amRNSNotice of Results and Investor Presentation
19th Feb 20217:00 amRNSInvestment in Dexters
10th Feb 20217:00 amRNSDirector Dealing
29th Jan 20214:42 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.